Wednesday, June 4, 2025
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Home 2024

Yearly Archives: 2024

2024 Watch List

Adding Terran Orbital (LLAP) $1.15 to Watch List. Risk Arbitrage Idea.

Editor / Curator -
2024 Watch List

Killer, 44-Page Report on GeoVax (GOVX).

Editor / Curator -
2024 Watch List

U.S. Population Classified as ‘Immunocompromised’ Explodes Higher, in Latest JAMA Report.

Editor / Curator -
All News

Adial Pharma (ADIL). Why Quit Drinking When You Can Just Cut...

Editor / Curator -
2024 Watch List

Interviews With Dr. Don Diamond, Lead Developer in the GeoVax (GOVX)...

Editor / Curator -
2024 Watch List

Geovax (GOVX) – City of Hope Covid Vaccine for Chronic Lymphocytic...

Editor / Curator -
2024 Watch List

The Extraordinary Dr. Koffman, Who Beat Leukemia.

Editor / Curator -
2024 Watch List

GeoVax (GOVX) Conference Call at 4:30 ET, the 29th.

Editor / Curator -
All News

Vaxart (VXRT) Gains $171 Million in Market Value After $9.2 Million...

Editor / Curator -
All News

GeoVax to Present at the 2024 BIO CEO & Investor Conference

Editor / Curator -
1...3456Page 4 of 6

Latest article

Cardiol Therapeutics (CRDL) May 2025 Presentation.

2023 Watch List Editor / Curator -
Click here to open. RELATED: Cardiol’s (CRDL) Game-Changing Solution for Heart Inflammation? | David Elsley CEO – Video Interview

Nice Bounce on Alkaline Water (WTER) up 81%.

All News Editor / Curator -
Well now that ain't bad, up 81%! Our outlook on The Alkaline Water Company, our "comeback of the decade" story, is "let's see what...

Zomedica Corp (ZOMDF) $0.05

Uncategorized Editor / Curator -
Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is headquartered in Ann Arbor, Michigan. Initially listed on the TSX Venture...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.